HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CD 02750

antineoplastic; structure in first source

Also Known As:

VLX 50

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - CD 02750: 2

Experts

1.	Fryknäs, Mårten: 2 articles (05/2017 - 07/2011)
2.	Gullbo, Joachim: 2 articles (05/2017 - 07/2011)
3.	Larsson, Rolf: 2 articles (05/2017 - 07/2011)
4.	Nygren, Peter: 2 articles (05/2017 - 07/2011)
5.	Westman, Gunnar: 2 articles (05/2017 - 07/2011)
6.	Bremberg, Ulf: 1 article (05/2017)
7.	Karlsson, Henning: 1 article (05/2017)
8.	Pandzic, Tatjana: 1 article (05/2017)
9.	Sjöblom, Tobias: 1 article (05/2017)
10.	Strese, Sara: 1 article (05/2017)

Related Diseases

1.	Neoplasms (Cancer) 07/15/2011 - "This compound, designated VLX 50, demonstrated a broad spectrum of activity when tested in a panel of PCPTCs representing different forms of leukemia and solid tumors and displayed a high tumor to normal cell activity. " 05/02/2017 - "The thiosemicarbazone CD 02750 (VLX50) was recently reported as a hit compound in a phenotype-based drug screen in primary cultures of patient tumor cells. "
2.	Leukemia 07/15/2011 - "This compound, designated VLX 50, demonstrated a broad spectrum of activity when tested in a panel of PCPTCs representing different forms of leukemia and solid tumors and displayed a high tumor to normal cell activity. "

Related Drugs and Biologics

1.	Thiosemicarbazones